You are here

Treatments

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Research into why protective antibodies fade after COVID-19 vaccines --NIH

  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.608 seconds.